US EditionNine of the largest pharma companies ink deals with Trump to lower drug prices
- On Friday, nine large U.S. and European drugmakers signed voluntary deals with President Donald Trump, who said Johnson & Johnson will join next week.
- Reviving the policy, the administration signed an executive order on May 12, 2025, aiming to cut drug costs by 30% to 80% and sent July letters to 17 drugmakers urging price cuts to `end global freeloading`.
- A 2024 RAND Corporation study found U.S. prescription drug prices are nearly three times higher than overseas, with branded drugs more than four times higher.
- Earlier this year the administration secured discounts from Eli Lilly, Novo Nordisk, Pfizer, AstraZeneca and EMD Serono in exchange for exemptions and fast-tracked reviews, while trade association PhRMA blamed pharmacy benefit managers and criticized most-favored-nation pricing.
- Because the U.S. is the largest market for many firms, the administration said half of the 10 largest European pharmaceutical companies earn most sales in the U.S., affecting global pricing.
21 Articles
21 Articles
(Washington = Yonhap News) Correspondent Lee Yu-mi = Nine global pharmaceutical companies have agreed to lower the prices of key drugs they sell in the United States amid pressure from the Donald Trump administration...
Trump Secures Major Pharma Deals to Slash U.S. Drug Prices.
PULSE POINTSWHAT HAPPENED: Nine major pharmaceutical companies have agreed to lower drug prices in deals with President Donald J. Trump.WHO WAS INVOLVED: President Trump and pharmaceutical companies, including Pfizer, AstraZeneca, Eli Lilly, Novo Nordisk, Merck, and others.WHEN & WHERE: The agreements were finalized on Friday in the United States.KEY QUOTE: “This represents the greatest victory for patient affordability in the history of Americ…
Trump's Pharmaceutical Price Slash: Major Deals Announced
Trump's Pharmaceutical Price Slash: Major Deals Announced The Trump administration, in a bid to lower medication costs, announced agreements with nine leading pharmaceutical companies aimed at aligning U.S. drug prices with those of other developed countries. This move is part of a larger initiative to reduce prices for both Medicaid and cash-paying consumers.During a White House press conference, President Trump, alongside pharmaceutical execut…
9 more drugmakers agree to Trump's policy to lower some prices
The White House announced Friday that nine additional pharmaceutical companies have agreed to follow President Trump's Most Favored Nation (MFN) drug pricing policy, with several of the companies throwing in several months worth of emergency drug supplies. According to a senior administration official, the following companies will abide by Trump's MFN pricing policy: Amgen, Boehringer [...]
Nine Drugmakers Strike Pricing Deals With Trump to Avoid Tariffs
President Donald Trump announced deals with nine pharmaceutical companies on Friday, the latest in a series of pacts designed to lower drug prices for some Americans in exchange for a three-year reprieve from threatened tariffs on their products.
Coverage Details
Bias Distribution
- 36% of the sources lean Left, 36% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
